TOFATAS XR (Tofacitinib (11mg))

Tofatas XR 11 mg tablet is indicated for the management of moderate to severe forms of rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis. Its primary function is to alleviate pain, tenderness, and swelling in the joints by minimizing inflammation in the body. Additionally, this medication plays a role in slowing down potential damage to bones and joints. The tablet may be prescribed alone or in conjunction with other medications, depending on the clinical scenario. It can be administered with or without meals, although it is advisable to take it consistently at the same time each day to maintain stable blood levels of the drug. The specific dosage will be determined by your healthcare provider based on your medical condition and any other treatments you might be receiving. It is important not to discontinue use without consulting your physician, as this could lead to a worsening of your symptoms. Routine blood tests may be necessary prior to initiating therapy with Tofatas XR 11 mg tablet, and it is contraindicated in individuals with any existing infections. Discuss with your healthcare professional if you have a history of conditions such as tuberculosis, shingles, liver or kidney issues, hepatitis B or C, or thromboembolic events. This medication may increase your susceptibility to infections or exacerbate existing ones, so it is prudent to avoid close contact with individuals who have contagious illnesses. The use of Tofatas XR 11 mg tablet is not recommended in pediatric populations under the age of 18, and it should be avoided in pregnant or breastfeeding individuals unless the potential benefits are deemed to outweigh the associated risks by a healthcare provider. Regular monitoring by your physician may be necessary during treatment.